Abnormal expression of Cdc25B has been reported in a number of carcinomas, such as non-small cell lung cancer [29], colorectal carcinomas [32], ovarian [33], esophageal [34], [35], prostate [36], gastric [37] and pancreatic [38] cancers. Here, CDC25B is linked to carcinoma.